Kurt A Gustafson's Net Worth

$4.85 Million

Estimate Recalculated Nov 11, 2024 02:54AM EST

Who is Kurt A Gustafson?

Kurt A Gustafson has an estimated net worth of $4.85 Million. This is based on reported shares across multiple companies, which include OmniAb, Inc., Xencor Inc, HALOZYME THERAPEUTICS INC, SPECTRUM PHARMACEUTICALS INC, ChromaDex Corp., and OmniAb, Inc..

SEC CIK

Kurt A Gustafson's CIK is 0001462354

Past Insider Trading and Trends

2022 was Kurt A Gustafson's most active year for acquiring shares with 7 total transactions. Kurt A Gustafson's most active month to acquire stocks was the month of May. 2019 was Kurt A Gustafson's most active year for disposing of shares, totalling 7 transactions. Kurt A Gustafson's most active month to dispose stocks was the month of February. 2012 saw Kurt A Gustafson paying a total of $564,500.00 for 164,471 shares, this is the most they've acquired in one year. In 2019 Kurt A Gustafson cashed out on 52,238 shares for a total of $558,466.11, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OmniAb, Inc. No price found

EVP, Finance and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 1
Form 3
—
0
—
—
0
No matching records found

Xencor Inc (XNCR) Snapshot price: $16.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+99.65%
5.99K
—
—
11.99K
Jun 13
Form 4
+19.97%
1K
$16.95
-$163,502.80
6.01K
Mar 6
Form 4
∞
5.01K
—
—
5.01K
Jun 20
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 24
Form 4/A
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jul 14
Form 3
—
0
—
—
0
No matching records found

HALOZYME THERAPEUTICS INC (HALO) Snapshot price: $59.21

Vice President and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 4
Form 4
+53.74%
12.47K
—
—
35.67K
Feb 2
Form 4
+190.00%
15.2K
—
—
23.2K
May 15
Form 4
—
0
—
—
0
Feb 2
Form 4
∞
8K
$5.88
$47,009.60
8K
Aug 9
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Feb 4
Form 3
—
0
—
—
0
No matching records found

SPECTRUM PHARMACEUTICALS INC No price found

EVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.44%
-36.97K
$0.71
-$26,080.87
317.26K
Scheduled
Mar 15 - Mar 16
Form 4
-4.78%
-36.17K
$0.67
-$24,424.26
720.42K
Scheduled
Feb 23 - Feb 24
Form 4
-8.39%
-36.68K
$3.65
-$134,036.54
400.45K
Scheduled
Mar 15 - Mar 16
Form 4
+34.00%
110.91K
$3.68
-$31,912.06
437.13K
Scheduled
Feb 18 - Feb 22
Form 4
-1.35%
-4.53K
$4.02
-$18,210.90
330.61K
Scheduled
Jan 19 - Jan 20
Form 4
-7.12%
-25.70K
$5.00
-$128,480.00
335.13K
Scheduled
Dec 14
Form 4
-2.03%
-7.46K
$2.28
-$16,979.78
360.83K
Scheduled
Mar 31 - Apr 1
Form 4
+79.56%
163.18K
—
—
368.29K
Mar 12
Form 4
-3.78%
-8.07K
$2.80
-$22,614.19
205.11K
Scheduled
Feb 19 - Feb 20
Form 4
-1.75%
-4.14K
$3.35
-$13,889.50
231.96K
Scheduled
Jan 16 - Jan 17
Form 4
-4.30%
-10.62K
$10.70
-$113,563.12
236.1K
Scheduled
Mar 29 - Apr 1
Form 4
-0.37%
-926.00
$9.90
-$9,167.40
246.71K
Scheduled
Mar 26
Form 4
-1.51%
-3.80K
$9.46
-$35,931.01
247.64K
Scheduled
Mar 25
Form 4
+18.44%
40K
—
—
256.9K
Feb 18
Form 4
-1.46%
-3.21K
$10.44
-$33,471.46
216.9K
Scheduled
Jan 16
Form 4
+43.42%
66.63K
$10.87
-$366,333.12
220.1K
Scheduled
Jan 9 - Jan 11
Form 4
-2.27%
-4.35K
$16.35
-$71,122.50
187.19K
Scheduled
Mar 28
Form 4
-0.67%
-1.30K
$17.38
-$22,594.00
191.54K
Scheduled
Mar 26
Form 4
-1.35%
-2.64K
$18.13
-$47,868.22
192.84K
Scheduled
Mar 22
Form 4
+11.05%
19.45K
—
—
195.48K
Jan 15
Form 4
-5.20%
-9.39K
$5.96
-$55,994.20
171.39K
Jun 3
Form 4
+33.58%
45.45K
$6.69
-$31,529.97
180.79K
Mar 28
Form 4
-1.03%
-1.41K
$6.61
-$9,320.10
135.34K
Mar 25
Form 4
-2.02%
-2.82K
$6.42
-$18,097.98
136.75K
Mar 22
Form 4
-1.74%
-2.47K
$5.91
-$14,603.61
139.57K
Feb 18
Form 4
-6.51%
-10.04K
$7.52
-$75,500.80
144.12K
Jun 3
Form 4
-1.04%
-1.52K
$5.96
-$9,089.00
144.5K
Mar 25
Form 4
+22.67%
26.99K
$6.08
-$18,300.80
146.02K
Mar 22
Form 4
-2.19%
-2.67K
$4.55
-$12,143.95
119.03K
Feb 18
Form 4
—
0
—
—
0
Dec 18
Form 4
-7.64%
-10.07K
$6.19
-$62,314.73
121.7K
Jun 3
Form 4
+20.18%
22.13K
$7.23
-$20,764.56
131.77K
Feb 18
Form 4
—
0
—
—
0
Dec 19
Form 4
-8.59%
-10.04K
$7.73
-$77,586.01
106.76K
Jun 3
Form 4
+14.62%
15K
—
—
117.59K
Mar 25
Form 4
∞
100K
—
—
100K
Jun 3
Form 3
—
0
—
—
0
No matching records found

ChromaDex Corp. (CDXC) Snapshot price: $3.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Nov 14
Form 3
—
0
—
—
0
No matching records found